This inventor holds 33 USPTO granted patents and 4 published patent applications. Top assignees: Jenrin Discovery, Inc., Bristol-Myers Squibb Pharma Company, Dupont Pharmaceuticals Company. Active years: 1994-2021.
Location History:
- Alhambra, CA (US) (1994)
- Wilmington, DE (US) (2001 - 2021)
Company Filing History:
27 out of 27 
1 out of 234 
1 out of 106 
Years Active: 1994-2021
Areas of Expertise:
Title: John Francis McElroy: Innovator in Cannabinoid Research
Introduction
John Francis McElroy, residing in Wilmington, DE, is a notable inventor with a remarkable portfolio of 32 patents. His contributions to the field of cannabinoid research have positioned him as a key player in developing innovative therapeutic solutions.
Latest Patents
Among his latest groundbreaking patents are "Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers." This invention introduces novel, diastereomeric pyrazolines that function as cannabinoid receptor blockers, providing pharmaceutical compositions and methods for treating various health conditions, such as obesity, diabetes, inflammatory disorders, cardiometabolic disorders, hepatic disorders, and cancers. Additionally, he has patented similar applications focused specifically on metabolic disorders, reaffirming his dedication to addressing significant health challenges.
Career Highlights
Throughout his career, John has held influential positions at various esteemed organizations. Notably, he has worked at Jenrin Discovery, Inc., and Wisys Technology Foundation, Inc., where he contributed to advancing research and development in cannabinoid applications.
Collaborations
In his journey, John has collaborated with distinguished peers, including Robert J Chorvat and Rajagopalan Parthasarathi. These partnerships have enhanced his research efforts and expanded the impact of his inventions.
Conclusion
John Francis McElroy's work exemplifies the innovative spirit inherent in modern scientific research. His extensive roster of patents underscores his commitment to finding solutions for serious medical conditions, particularly in the realm of cannabinoid therapies. Through his ongoing contributions, McElroy continues to shape the future of health-related innovations.